跳至主要内容
临床试验/NL-OMON31841
NL-OMON31841撤回4 期

Treatment of Complex Regional Pain Syndrome type I;A randomised, double-blind, placebo-controlled study with multiple rounds of S(+)-ketamine infusions (The Ket Ket Study) - KetKet Study

eids Universitair Medisch Centrum0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
撤回
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Patients are diagnosed with CRPS-1 according to the IASP-criteria;
  • Patients must report a NRS spontaneous pain score of 5 or higher;
  • The age of the patient is between 18 and 70 years;
  • Patients must give a written informed consent;

排除标准

  • Patients who are not able to give informed consent;
  • Patients suffering from other syndromes/diseases interfering with pain ratings;
  • Patients who have had previous ketamine continuous infusion;
  • Patients with co-morbidity such as: kidney disease, severe liver disease, nerve damage in the
  • affected area, increased intracranial pressure, infectious disease, epilepsy, a psychiatric
  • illness, thyroid disease, cancer, cardiac disease, pulmonary disease, severe or uncontrolled
  • hypertension, aneurysm, glaucoma, history of cerebral vascular accident (CVA) < 1 year;
  • Patients who are pregnant.

研究者

相似试验